Athyrium Capital Management as of Dec. 31, 2017
Portfolio Holdings for Athyrium Capital Management
Athyrium Capital Management holds 5 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aegerion Pharmaceuticals 2% Du cvbond | 45.9 | $78M | 95M | 0.82 | |
| Vivus Inc note 4.500% 5/0 | 22.9 | $39M | 60M | 0.65 | |
| Ptc Therapeutics Inc conv bd us | 21.7 | $37M | 46M | 0.81 | |
| Sucampo Pharmaceuticals Inc dbcv 3.250%12/1 | 8.6 | $15M | 12M | 1.22 | |
| Apollo Endosurgery | 0.8 | $1.4M | 252k | 5.60 |
